| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/25/1996 | DE4438767A1 Combination pharmaceuticals with reduced risk of liver damage |
| 04/25/1996 | CA2202661A1 Methods for treating resistant tumors |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |
| 04/25/1996 | CA2202465A1 Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans |
| 04/25/1996 | CA2202389A1 Agent for preventing and treating diarrhea |
| 04/25/1996 | CA2202173A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707854A2 Compositions for the treatment of gastronitestinal disorders containing bismuth and an antimicrobial |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707495A1 Compositions for treating hypoxia-associated ocular complications |
| 04/24/1996 | EP0707480A1 Antineoplastic compositions and methods of use |
| 04/24/1996 | EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 04/24/1996 | EP0380542B1 Method for treating malignancy and autoimmune disorders in humans |
| 04/23/1996 | US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| 04/23/1996 | US5510339 Method for the treatment of bronchial asthma by administration of topical anesthetics |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011021A2 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | WO1996011009A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
| 04/18/1996 | WO1996011006A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation |
| 04/18/1996 | WO1996011005A2 Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases |
| 04/18/1996 | WO1996011004A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 04/18/1996 | WO1996011000A1 Methods of treating migraine |
| 04/18/1996 | WO1996010998A1 Anti-acne method and composition |
| 04/18/1996 | WO1996010910A1 Method and formulation of stimulating nitric oxide synthesis |
| 04/18/1996 | DE4436352A1 Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen Method for the diagnostic assessment and monitoring and drugs for the treatment of shock in humans |
| 04/18/1996 | CA2202272A1 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/17/1996 | EP0706792A1 Method of potentiating an immune response and compositions therefor |
| 04/17/1996 | EP0706581A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706387A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/17/1996 | EP0706386A1 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 04/17/1996 | EP0706369A1 Stimulation of tanning by dna fragments |
| 04/17/1996 | EP0683665A4 Magnetically responsive composition for carrying biologically active substances and methods of production and use. |
| 04/17/1996 | EP0651822B1 Diagnostic method |
| 04/17/1996 | EP0493468B1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/17/1996 | EP0429534B1 Molecular conjugates containing cell membrane-blending agents |
| 04/16/1996 | US5508310 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 04/16/1996 | US5508306 Used for treatment of benign prostatic hyperplasia, lowering intraocular pressure and inhibiting cholesterol synthesis |
| 04/16/1996 | US5508262 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
| 04/16/1996 | US5508045 Administering nitric oxide donor |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010422A1 Conjugate for treating inflammatory diseases |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | WO1996010402A1 Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| 04/11/1996 | WO1996010389A1 Pharmaceutical composition |
| 04/11/1996 | WO1996005845A3 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/11/1996 | DE4435661A1 Mittel zur Behandlung von Papillomvirus-positiven gutartigen, malignen und prämalignen Läsionen Agents for the treatment of papilloma virus-positive benign, malignant and pre-malignant lesions |
| 04/11/1996 | DE4431175A1 Neue, Chelatbildner enthaltende Arzneimittel New, high chelating drugs |
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/10/1996 | EP0705600A1 Use of 5-HT1F-receptor agonists for the treatment of migraine |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705111A1 Agent with influences hyperactive immunological effector cells |
| 04/10/1996 | EP0705098A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 04/10/1996 | EP0547079B1 New use of a monoclonal antibody |
| 04/10/1996 | EP0450095B1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 04/10/1996 | CN1120316A HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS |
| 04/10/1996 | CN1120304A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1119940A Combination treatment for inhibiting bone loss |
| 04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
| 04/09/1996 | US5505961 Increasing solubility |
| 04/06/1996 | CA2159767A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009827A2 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 04/04/1996 | WO1996009806A2 Inhibition of hair growth |
| 04/04/1996 | DE4435087A1 Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen Conjugate for treatment of infectious and autoimmune diseases |
| 04/04/1996 | DE19536246A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | DE19536245A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | DE19536244A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | CA2200436A1 Combination therapy for hypercholesterolemia |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704206A1 Pharmaceutical composition |
| 04/03/1996 | EP0704199A1 Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0703784A1 Release and mobilisation of haematopoietic cells |
| 04/03/1996 | EP0703782A1 H2-antagonists as immune stimulants in bacterial infections of cattle or swine |
| 04/03/1996 | EP0703731A1 Food and/or pharmaceutical composition having a low polyamine content, and therapeutical uses thereof |
| 04/03/1996 | EP0490891B1 Drug containing matrix |
| 04/02/1996 | US5504081 Administering nicotinergic acetylcholine receptor antagonists and agonists |
| 04/02/1996 | US5503973 Method for inhibition of viral morphogenesis |
| 03/28/1996 | WO1996009543A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | WO1996009071A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 03/28/1996 | WO1996009057A1 Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men |
| 03/28/1996 | WO1996009052A1 A method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds |
| 03/28/1996 | WO1996009051A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 03/28/1996 | WO1996009044A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 03/28/1996 | WO1996009043A1 Methods for the treatment of inflammatory joint disease |
| 03/28/1996 | WO1996009042A1 Compositions and methods for the control of smoking |
| 03/28/1996 | WO1996009038A2 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
| 03/28/1996 | DE4435368A1 Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann The use of aromatase inhibitors for the manufacture of a medicament for treating a relative androgen deficiency in men |
| 03/28/1996 | DE4433890A1 Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active agent and a non-prestigious as foreign, native protein |
| 03/28/1996 | CA2200755A1 Compositions and methods for the control of smoking |
| 03/28/1996 | CA2200709A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | CA2200205A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |